Squarepoint’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Squarepoint’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,588	Closed	-$510K	–	3457
2020 Q3	$510K	Buy	+4,588	New	+$493K	0.01%	1423
2018 Q4	–	Sell	-2,703	Closed	-$216K	–	2463
2018 Q3	$216K	Sell	2,703 -8,314	-75%	-$775K	﹤0.01%	1737
2018 Q2	$1.09M	Buy	+11,017	New	+$952K	0.01%	861

Other funds holding CBPO

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Squarepoint's CBPO Position: Q4 2020 in Review

Squarepoint sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2020, closing a stake of 4,588 shares — an estimated $510K sold.

Squarepoint first reported a position in CBPO in Q2 2018 and held it in 3 quarters. The position peaked at $1.09M in Q2 2018. 89 funds tracked by Wall St. Rank hold CBPO as of Q4 2020.

Squarepoint reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2020 after selling out during the quarter.
Squarepoint sold 4,588 China Biologic Products Holdings, Inc. shares in Q4 2020, an estimated $510K.
Squarepoint first reported a position in China Biologic Products Holdings, Inc. in Q2 2018 and held it in 3 quarters.
Squarepoint's China Biologic Products Holdings, Inc. position peaked at $1.09M in Q2 2018.
89 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2020.

Based on Squarepoint's 13F filing for Q4 2020, filed 16 Feb 2021.